Form 8-K - Current report:
SEC Accession No. 0001564590-17-013224
Filing Date
2017-07-06
Accepted
2017-07-06 08:10:21
Documents
3
Period of Report
2017-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20170701.htm 8-K 33444
2 EX-99.1 vktx-ex991_17.htm EX-99.1 13399
3 GRAPHIC g201707051749581587640.jpg GRAPHIC 3707
  Complete submission text file 0001564590-17-013224.txt   53331
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 17950863
SIC: 2834 Pharmaceutical Preparations